BioXcel Therapeutics (BTAI) Interest Coverage Ratio Growth (3y) (2020 - 2026)
BioXcel Therapeutics (BTAI) Interest Coverage Ratio Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.36 Mn | 24.36 Mn | 160,000.00 | 47.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.05% |
| Mar 31, 2026 | -19.71% |
| Dec 31, 2025 | 115.01% |
| Sep 30, 2025 | -23.63% |
| Jun 30, 2025 | -34.80% |
| Mar 31, 2025 | -55.37% |
| Dec 31, 2024 | 26.01% |
| Sep 30, 2024 | -115.59% |
| Jun 30, 2024 | 86.06% |
| Mar 31, 2024 | -195.07% |
| Dec 31, 2023 | 87.77% |
| Sep 30, 2023 | -210.31% |
| Jun 30, 2023 | -238.29% |
| Mar 31, 2023 | -75.29% |
| Dec 31, 2022 | -26.02% |
| Sep 30, 2022 | -44.63% |
| Jun 30, 2022 | -52.99% |
| Mar 31, 2022 | -17.13% |
| Sep 30, 2021 | -911.83% |
| Jun 30, 2021 | -20,578.05% |